Smith, Moore & Co. Medtronic PLC Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Medtronic PLC stock. As of the latest transaction made, Smith, Moore & Co. holds 13,568 shares of MDT stock, worth $1.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

13,568

Previous 12,890 5.26%

Holding current value

$1.1 Million

Previous $1.01 Million 20.41%

% of portfolio

0.12%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.84 - $91.03 $52,097 - $61,718	678 Added 5.26%	13,568 $1.22 Million
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $11,098 - $12,269	-141 Reduced 1.08%	12,890 $1.01 Million
Q1 2024 May 10, 2024	BUY	$82.84 - $88.09 $35,952 - $38,231	434 Added 3.45%	13,031 $1.14 Million
Q4 2023 Feb 13, 2024	SELL	$69.43 - $83.43 $1,319 - $1,585	-19 Reduced 0.15%	12,597 $1.04 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $547 - $632	7 Added 0.06%	12,616 $988,000
Q2 2023 Aug 11, 2023	BUY	$79.47 - $91.38 $80,264 - $92,293	1,010 Added 8.71%	12,609 $1.11 Million
Q1 2023 May 12, 2023	BUY	$76.72 - $87.58 $60,915 - $69,538	794 Added 7.35%	11,599 $935,000
Q4 2022 Feb 13, 2023	BUY	$76.18 - $87.74 $34,814 - $40,097	457 Added 4.42%	10,805 $839,000
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $21,641 - $25,543	268 Added 2.66%	10,348 $836,000
Q2 2022 Aug 12, 2022	BUY	$87.4 - $113.09 $5,331 - $6,898	61 Added 0.61%	10,080 $905,000
Q1 2022 May 12, 2022	BUY	$100.58 - $112.38 $92,634 - $103,501	921 Added 10.12%	10,019 $1.11 Million
Q4 2021 Feb 08, 2022	BUY	$99.53 - $127.75 $77,633 - $99,645	780 Added 9.38%	9,098 $941,000
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $15,466 - $17,031	-126 Reduced 1.49%	8,318 $1.04 Million
Q2 2021 Aug 10, 2021	BUY	$118.19 - $131.5 $5,554 - $6,180	47 Added 0.56%	8,444 $1.05 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $11,118 - $11,974	100 Added 1.21%	8,397 $992,000
Q4 2020 Feb 16, 2021	BUY	$100.57 - $117.14 $100 - $117	1 Added 0.01%	8,297 $972,000
Q2 2020 Aug 10, 2020	BUY	$84.11 - $103.33 $18,924 - $23,249	225 Added 2.79%	8,296 $761,000
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $72 - $121	-1 Reduced 0.01%	8,071 $728,000
Q4 2019 Feb 07, 2020	SELL	$104.49 - $114.54 $62,798 - $68,838	-601 Reduced 6.93%	8,072 $916,000
Q3 2019 Nov 07, 2019	BUY	$98.02 - $111.18 $14,114 - $16,009	144 Added 1.69%	8,673 $942,000
Q2 2019 Aug 15, 2019	BUY	$84.15 - $99.38 $2,440 - $2,882	29 Added 0.34%	8,529 $831,000
Q1 2019 May 07, 2019	BUY	$82.45 - $93.79 $5,771 - $6,565	70 Added 0.83%	8,500 $774,000
Q4 2018 Feb 15, 2019	SELL	$85.8 - $99.49 $10,553 - $12,237	-123 Reduced 1.44%	8,430 $767,000
Q3 2018 Nov 15, 2018	BUY	$85.91 - $99.17 $34,621 - $39,965	403 Added 4.94%	8,553 $841,000
Q4 2017 Feb 09, 2018	SELL	$76.93 - $83.5 $39,080 - $42,418	-508 Reduced 5.87%	8,150 $658,000
Q3 2017 Nov 02, 2017	BUY	$77.71 - $84.6 $672,813 - $732,466	8,658	8,658 $673,000

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account